InVivoMAb anti-rat IL-4

Mitsuoka N, Iwagaki H, Ozaki M, et al. The impact of portal infusion with donor-derived bone marrow cells and intracellular cytokine expression of graft-infiltrating lymphocytes on the graft survival in rat small bowel transplant model. Transpl Immunol. 2004,13(3):155-60.

Salomon I, Netzer N, Wildbaum G, et al. Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis. J Immunol. 2002,169(5):2685-93.

Tran GT, Carter N, He XY, et al. Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4. Int Immunol. 2001,13(9):1109-20.

Uchikawa R, Matsuda S, Arizono N. Suppression of gamma interferon transcription and production by nematode excretory-secretory antigen during polyclonal stimulation of rat lymph node T cells. Infect Immun. 2000,68(11):6233-9.

Saoudi A, Simmonds S, Huitinga I, et al. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells. J Exp Med. 1995,182(2):335-44.